首页> 美国卫生研究院文献>OncoTargets and therapy >Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population

【2h】

Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population

机译：索拉非尼在晚期分化和甲状腺髓样癌中的疗效：在土耳其人群中的经验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundAntivascular endothelial growth factor tyrosine kinase inhibitors have been used recently in the treatment of advanced differentiated thyroid cancer (DTC) and medullary thyroid cancer (MTC). Off-label sorafenib is used in Turkey with special permission by the Ministry of Health for this indication.

机译：背景技术抗血管内皮生长因子酪氨酸激酶抑制剂最近已用于治疗晚期分化型甲状腺癌（DTC）和甲状腺髓样癌（MTC）。在土耳其，未经卫生部特别许可，将索拉非尼用于标签上。

著录项

期刊名称 OncoTargets and therapy
作者
Mustafa Benekli; Suayib Yalcin; Metin Ozkan; Emin Tamer Elkiran; Alper Sevinc; Devrim Cabuk; Hasan Senol Coskun; Berna Oksuzoglu; Banu Bayar; Akif Akbulat; Ahmet Ozet;
展开▼
作者单位

展开▼
年(卷),期 2015(8),-1
年度 2015
页码 1–5
总页数 5
原文格式 PDF
正文语种
中图分类应用微生物学;肿瘤学;
关键词
advanced thyroid cancer sorafenib overall survival;

机译：晚期甲状腺癌;索拉非尼;总生存;

相似文献

外文文献
中文文献
专利

1. Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population [J] . Mustafa Benekli, Suayib Yalcin, Metin Ozkan, OncoTargets and therapy . 2015,第4期

机译：索拉非尼在晚期分化和甲状腺髓样癌中的疗效：在土耳其人群中的经验
2. Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review [J] . Zohreh Maghsoomi, Zahra Emami, Ramin Malboosbaf, BMC Cancer . 2021,第1期

机译：肽受体放射性核素疗法治疗晚期放射性碘 - 难治性分化甲状腺癌和转移性髓质甲状腺癌的疗效和安全性：系统评价
3. EFFICACY AND SAFETY PROFILE OF LENVATINIB AND SORAFENIB IN THE TREATMENT OF ADULT PATIENTS WITH ADVANCED RADIOACTIVE-IODINE-REFRACTORY DIFFERENTIATED THYROID CANCER (RR-DTC) [J] . Kawalec P. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：LENVATINIB和SORAFENIB在先进的放射性-碘-碘耐药性甲状腺癌（RR-DTC）治疗成人患者中的功效和安全性
4. Clinical Engineering and Clinical Dosimetry in Patients with Differentiated Thyroid Cancer Undergoing Thyroid Remnant Ablation with Radioiodine-131 [C] . M. Medvedec, D. Dodig 12th Mediterranean conference on medical and biological engineering and computing 2010 . 2010

机译：放射性碘131消融甲状腺分化型甲状腺癌患者的临床工程和临床剂量
5. Genetic differentiation of the large turkey louse (Chelopistes meleagridis) populations reveals limited movement of turkeys across the Mississippi River. [D] . LeCompte, Kimberly G. 2013

机译：大火鸡虱（Chelopistes meleagridis）种群的遗传分化表明，火鸡在密西西比河上的活动有限。
6. Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review [O] . Zohreh Maghsoomi, Zahra Emami, Ramin Malboosbaf, 2021

机译：肽受体放射性核素治疗在高级放射性碘 - 难以分化的甲状腺癌和转移性髓质甲状腺癌中的疗效和安全性：系统评价
7. Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population [O] . Mustafa Benekli, suayib yalcin, metin ozkan, 2014

机译：Sorafenib在高级分化和髓质甲状腺癌中的疗效：土耳其人口的经验

相关主题

Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population

摘要

著录项

相似文献

相关主题

期刊订阅